• Alcamo, A.M., Wolf, M.S., Alessi, L.J., Chong, H.J., Green, M., Williams, J.V.,Simon, D.W., 2020. Successful use of cidofovir in an immunocompetent child with severe adenoviral sepsis. Pediatrics, 145, e20191632.

  • Baum, A., Ajithdoss, D., Copin, R., Zhou, A., Lanza, K., Negron, N., Ni, M., Wei, Y., Mohammadi, K., Musser, B., et al., 2020. REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters. Science, 370, 1110-1115.

  • Bradley, R.R., Lynch, D.M., Iampietro, M.J., Borducchi, E.N.,Barouch, D.H., 2012a. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection. J. Virol., 86, 625-629.

  • Bradley, R.R., Maxfield, L.F., Lynch, D.M., Iampietro, M.J., Borducchi, E.N.,Barouch, D.H., 2012b. Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions. J. Virol., 86, 1267-1272.

  • Cao, Y., Su, B., Guo, X., Sun, W., Deng, Y., Bao, L., Zhu, Q., Zhang, X., Zheng, Y., Geng, C., et al., 2020. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells. Cell, 182, 73-84.e16.

  • Chamberlain, J.M., Sortino, K., Sethna, P., Bae, A., Lanier, R., Bambara, R.A.,Dewhurst, S., 2019. Cidofovir diphosphate inhibits adenovirus 5 DNA polymerase via both nonobligate chain termination and direct inhibition, and polymerase mutations confer Cidofovir resistance on intact virus. Antimicrob. Agents Chemother., 63, e01925-18.

  • Chang, S.Y., Lee, C.N., Lin, P.H., Huang, H.H., Chang, L.Y., Ko, W., Chang, S.F., Lee, P.I., Huang, L.M.,Kao, C.L., 2008. A community-derived outbreak of adenovirus type 3 in children in Taiwan between 2004 and 2005. J. Med. Virol., 80, 102-112.

  • Chen, L., Lu, J., Yue, J., Wang, R., Du, P., Yu, Y., Guo, J., Wang, X., Jiang, Y., Cheng, K., Yang, Z.,Zheng, T., 2023. A humanized anti-human adenovirus 55 monoclonal antibody with good neutralization ability. Front. Immunol., 14, 1132822.

  • Doan, M.L., Mallory, G.B., Kaplan, S.L., Dishop, M.K., Schecter, M.G., Mckenzie, E.D., Heinle, J.S.,Elidemir, O., 2007. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J. Heart Lung Transplant., 26, 883-889.

  • Fanourgiakis, P., Georgala, A., Vekemans, M., Triffet, A., De Bruyn, J.M., Duchateau, V., Martiat, P., De Clercq, E., Snoeck, R., Wollants, E., Rector, A., Van Ranst, M.,Aoun, M., 2005. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin. Infect. Dis., 40, 199-201.

  • Feng, Y., Sun, X., Ye, X., Feng, Y., Wang, J., Zheng, X., Liu, X., Yi, C., Hao, M., Wang, Q., Li, F., Xu, W., Li, L., Li, C., Zhou, R., Chen, L.,Feng, L., 2018. Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity. Virology, 518, 272-283.

  • Fu, Y., Tang, Z., Ye, Z., Mo, S., Tian, X., Ni, K., Ren, L., Liu, E.,Zang, N., 2019. Human adenovirus type 7 infection causes a more severe disease than type 3. BMC Infect. Dis., 19, 36.

  • Gahery-Segard, H., Farace, F., Godfrin, D., Gaston, J., Lengagne, R., Tursz, T., Boulanger, P.,Guillet, J.G., 1998. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J. Virol., 72, 2388-2397.

  • Ganapathi, L., Arnold, A., Jones, S., Patterson, A., Graham, D., Harper, M.,Levy, O., 2016. Use of cidofovir in pediatric patients with adenovirus infection. F1000Res, 5, 758.

  • Khanal, S., Ghimire, P.,Dhamoon, A.S., 2018. The repertoire of adenovirus in human disease: the innocuous to the deadly. Biomedicines, 6, 30.

  • Li, H., Shao, L., Liu, Z., Liu, Q.,Xiang, Y., 2025. Molecular mechanisms of the viral encoded chaperone 100K in capsid folding and assembly of adenovirus. Nat. Commun., 16, 4013.

  • Li, X., Zhou, Z., Liu, W., Fan, Y., Luo, Y., Li, K., Zheng, Z., Tian, X.,Zhou, R., 2021. Chinese tree shrew: a permissive model for in vitro and in vivo replication of human adenovirus species B. Emerg. Microb. Infect., 10, 424-438.

  • Liu, L., Wang, P., Nair, M.S., Yu, J., Rapp, M., Wang, Q., Luo, Y., Chan, J.F., Sahi, V., Figueroa, A., et al., 2020. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature, 584, 450-456.

  • Liu, X., Li, Z., Li, X., Zhang, X., Zheng, Y., Su, W., Feng, Y., Liu, Y., Wu, W., Sun, X., et al., 2024. Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews. Emerg. Microb. Infect., 13, 2307513.

  • Lu, J., Wang, R., Huang, Y., Yu, Y., Zhou, X., Huang, P.,Yang, Z., 2020. A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein. Virology, 543, 20-26.

  • Lynch, J.P., 3rd, Fishbein, M.,Echavarria, M., 2011. Adenovirus. Semin. Respir. Crit. Care Med., 32, 494-511.

  • Neofytos, D., Ojha, A., Mookerjee, B., Wagner, J., Filicko, J., Ferber, A., Dessain, S., Grosso, D., Brunner, J., Flomenberg, N.,Flomenberg, P., 2007. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol. Blood Marrow Transplant., 13, 74-81.

  • Sun, B., He, H., Wang, Z., Qu, J., Li, X., Ban, C., Wan, J., Cao, B., Tong, Z.,Wang, C., 2014. Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study. Crit. Care, 18, 456.

  • Tian, X., Fan, Y., Liu, Z., Zhang, L., Liao, J., Zhou, Z., Li, X., Liu, T., Liu, W., Qiu, H.,Zhou, R., 2018. Broadly neutralizing monoclonal antibodies against human adenovirus types 55, 14p, 7, and 11 generated with recombinant type 11 fiber knob. Emerg. Microb. Infect., 7, 206.

  • Tian, X., Li, C., Xue, C., Li, X., Zhou, Z.,Zhou, R., 2013. Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3. Virus Res., 177, 189-193.

  • Varghese, R., Mikyas, Y., Stewart, P.L.,Ralston, R., 2004. Postentry neutralization of adenovirus type 5 by an antihexon antibody. J. Virol., 78, 12320-12332.

  • Wang, H., Li, Z.Y., Liu, Y., Persson, J., Beyer, I., Moller, T., Koyuncu, D., Drescher, M.R., Strauss, R., Zhang, X.B., Wahl, J.K., 3rd, Urban, N., Drescher, C., Hemminki, A., Fender, P.,Lieber, A., 2011. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat. Med., 17, 96-104.

  • Wohlfart, C., 1988. Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms. J. Virol., 62, 2321-2328.

  • Wu, C., Zhang, Y., Liang, A., Wu, X., Zhu, Y., Huang, Z., Wang, J., Deng, Y., Pan, L., Wang, A., Deng, F., Xia, J., 2025. Comparative analysis between genotypes of adenovirus isolates from hospitalized children with acute respiratory tract infections and clinical manifestations in Wuhan, China, from June 2022 to September 2023. Virol. Sin., 40: 50-60.

  • Xie, L., Zhang, B., Zhou, J., Huang, H., Zeng, S., Liu, Q., Xie, Z., Gao, H., Duan, Z.,Zhong, L., 2018. Human adenovirus load in respiratory tract secretions are predictors for disease severity in children with human adenovirus pneumonia. Virol. J., 15, 123.

  • Zhang, T.G., Li, A.H., Lyu, M., Chen, M., Huang, F.,Wu, J., 2015. Detection of respiratory viral and bacterial pathogens causing pediatric community-acquired pneumonia in Beijing using real-time PCR. Chronic Dis Transl Med, 1, 110-116.